TheraLink™ HER Family Assay

Enabling therapeutic decisions based on drug target activity
in primary, recurrent or metastatic breast cancer

Preclinical Biomarker Discovery

  • Target and Lead Discovery
  • Target and Model Validation
  • Assessment of Late-stage Preclinical Candidates

Proteomic Clinical Applications

  • Early Proof-of-Concept in Clinical Trials
  • Surrogate Marker Development
  • Patient Stratification Strategies